TNIP1 and astrocytoma (excluding glioblastoma): Interestingly, glioma patients with high TNIP1 levels in all neoplasm tissues, including glioblastoma, oligodendroglioma and astrocytoma, showed significantly shorter survival compared with glioma patients with low TNIP1 levels (Figure 1B,1,1).